Zkusit zdarma
Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

LYEL
Cena:
$ 17.46
+0.16 (0.92%)
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

0:20 23-05-2026

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript...

Lyell Immunopharma, Inc. (LYEL) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conference Transcript

Lyell Immunopharma, Inc. (LYEL) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conference Transcript

19:10 22-05-2026

Lyell Immunopharma, Inc. (LYEL) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conferenc...

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL)

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL)

10:36 19-05-2026

Lyell Immunopharma (LYEL) is technically in oversold territory now, so the heavy selling pressure mi...

Lyell Immunopharma Announces Participation in May Investor Conferences

Lyell Immunopharma Announces Participation in May Investor Conferences

8:00 12-05-2026

SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL...

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

16:05 06-05-2026

PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line se...

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Increase in Short Interest

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Increase in Short Interest

3:39 19-04-2026

Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report) was the recipient of a significant increas...

Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

1:41 17-04-2026

Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transc...

Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference

Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference

8:00 07-04-2026

SOUTH SAN FRANCISCO, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LY...

Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX)

Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX)

1:24 06-04-2026

Mangoceuticals (NASDAQ: MGRX - Get Free Report) and Lyell Immunopharma (NASDAQ: LYEL - Get Free Repo...

Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

16:05 12-03-2026

SOUTH SAN FRANCISCO, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LY...

Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer

Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer

8:00 09-03-2026

SOUTH SAN FRANCISCO, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LY...

Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript

16:55 06-03-2026

Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript...

Lyell Immunopharma Announces Participation in March Investor Conferences

Lyell Immunopharma Announces Participation in March Investor Conferences

8:00 23-02-2026

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE...

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 4.6% – Here’s What Happened

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 4.6% – Here’s What Happened

5:46 04-01-2026

Shares of Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report) were down 4.6% during mid-day tr...

Lyell Immunopharma (NASDAQ:LYEL) Trading Down 6.7% – Should You Sell?

Lyell Immunopharma (NASDAQ:LYEL) Trading Down 6.7% – Should You Sell?

2:36 28-12-2025

Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report) shares traded down 6.7% during trading on ...

Lyell Immunopharma (NASDAQ:LYEL) Sets New 12-Month High – Here’s What Happened

Lyell Immunopharma (NASDAQ:LYEL) Sets New 12-Month High – Here’s What Happened

2:20 07-12-2025

Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report)'s share price reached a new 52-week high o...

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025

16:05 12-11-2025

Acquired exclusive global rights to LYL273, a novel GCC-targeted CAR T-cell product candidate that h...

Lyell Immunopharma Announces Participation in September Investor Conferences

Lyell Immunopharma Announces Participation in September Investor Conferences

16:05 02-09-2025

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LY...

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025

16:05 12-08-2025

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE...

Lyell Immunopharma Announces up to $100 Million Equity Private Placement

Lyell Immunopharma Announces up to $100 Million Equity Private Placement

8:00 25-07-2025

SOUTH SAN FRANCISCO, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE...

close

LYELL IMMUNOPHARMA ANNOUNCES INITIATION OF PATIENT DOSING IN FIRST-OF-ITS-KIND PHASE 3 HEAD-TO-HEAD CAR T-CELL CLINICAL TRIAL IN AGGRESSIVE LARGE B-CELL LYMPHOMA

12-02-2026
SOUTH SAN FRANCISCO, CALIF., FEB. 12, 2026 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA PRESENTS NEW CLINICAL DATA FROM ONGOING TRIAL OF RONDE-CEL SHOWING HIGH RATES OF DURABLE COMPLETE RESPONSES IN PATIENTS WITH LARGE B-CELL LYMPHOMA AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

07-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 07, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE THIRD QUARTER 2025

12-11-2025
ACQUIRED EXCLUSIVE GLOBAL RIGHTS TO LYL273, A NOVEL GCC-TARGETED CAR T-CELL PRODUCT CANDIDATE THAT H...
Více zde

LYELL IMMUNOPHARMA ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO A NEXT-GENERATION CAR T-CELL PRODUCT CANDIDATE IN CLINICAL DEVELOPMENT FOR METASTATIC COLORECTAL CANCER

10-11-2025
LYL273 HAS DEMONSTRATED A 67% OVERALL RESPONSE RATE, AN 83% DISEASE CONTROL RATE, AND A MANAGEABLE S...
Více zde

LYELL ANNOUNCES TWO ORAL PRESENTATIONS FROM THE PHASE 1/2 CLINICAL TRIAL OF RONDE-CEL FOR THE TREATMENT OF AGGRESSIVE LARGE B-CELL LYMPHOMA AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

03-11-2025
SOUTH SAN FRANCISCO, CALIF., NOV. 03, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES THE INITIATION OF A PHASE 3 HEAD-TO-HEAD CAR T-CELL THERAPY CLINICAL TRIAL IN AGGRESSIVE LARGE B-CELL LYMPHOMA AND FORMATION OF EXPERT STEERING COMMITTEE

03-09-2025
PINACLE - H2H WILL EVALUATE RONDECABTAGENE AUTOLEUCEL (RONDE-CEL) VERSUS INVESTIGATOR'S CHOICE OF AP...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES PARTICIPATION IN SEPTEMBER INVESTOR CONFERENCES

02-09-2025
SOUTH SAN FRANCISCO, CALIF., SEPT. 02, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LY...
Více zde

LYELL IMMUNOPHARMA REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE SECOND QUARTER 2025

12-08-2025
SOUTH SAN FRANCISCO, CALIF., AUG. 12, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES UP TO $100 MILLION EQUITY PRIVATE PLACEMENT

25-07-2025
SOUTH SAN FRANCISCO, CALIF., JULY 25, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA TO PARTICIPATE IN THE H.C. WAINWRIGHT “HCW@HOME” SERIES

23-06-2025
SOUTH SAN FRANCISCO, CALIF., JUNE 23, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES POSITIVE NEW CLINICAL DATA DEMONSTRATING HIGH RATES OF DURABLE COMPLETE RESPONSES FROM THE PHASE 1/2 TRIAL OF LYL314 FOR THE TREATMENT OF AGGRESSIVE LARGE B-CELL LYMPHOMA

17-06-2025
SOUTH SAN FRANCISCO, CALIF., JUNE 17, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA STRENGTHENS CLINICAL AND COMMERCIAL CAPABILITIES WITH KEY BOARD AND EXECUTIVE APPOINTMENTS

09-06-2025
SOUTH SAN FRANCISCO, CALIF., JUNE 09, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA TO PARTICIPATE IN THE GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE

04-06-2025
SOUTH SAN FRANCISCO, CALIF., JUNE 04, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE FIRST QUARTER 2025

13-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 13, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYEL...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES ORAL PRESENTATION OF NEW CLINICAL DATA FROM THE PHASE 1/2 TRIAL OF LYL314 FOR THE TREATMENT OF LARGE B-CELL LYMPHOMA AT THE INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMA (ICML) 2025

01-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 01, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYEL...
Více zde

LYELL IMMUNOPHARMA RECEIVES REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR LYL314 FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY LARGE B-CELL LYMPHOMA

15-04-2025
SOUTH SAN FRANCISCO, CALIF., APRIL 15, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LY...
Více zde

LYELL IMMUNOPHARMA REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2024

11-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 11, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LY...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

18-02-2025
SOUTH SAN FRANCISCO, CALIF., FEB. 18, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL TO HIGHLIGHT VISION FOR ITS NEXT-GENERATION CAR T-CELL THERAPY PIPELINE AT 43RD ANNUAL JP MORGAN HEALTHCARE CONFERENCE

09-01-2025
SOUTH SAN FRANCISCO, CALIF., JAN. 09, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL PRESENTS POSITIVE INITIAL CLINICAL DATA FROM THE PHASE 1-2 CLINICAL TRIAL OF IMPT-314 FOR THE TREATMENT OF B-CELL LYMPHOMA AT THE 2024 ASH ANNUAL MEETING

09-12-2024
SOUTH SAN FRANCISCO, CALIF., DEC. 09, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL ANNOUNCES PRESENTATION OF INITIAL CLINICAL DATA FROM THE PHASE 1-2 CLINICAL TRIAL OF IMPT-314 FOR THE TREATMENT OF B-CELL LYMPHOMA AT THE 2024 AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

05-11-2024
SOUTH SAN FRANCISCO, CALIF., NOV. 05, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA COMPLETES ACQUISITION OF IMMPACT BIO

31-10-2024
SOUTH SAN FRANCISCO, CALIF., OCT. 31, 2024 (GLOBE NEWSWIRE) --  LYELL IMMUNOPHARMA, INC. (NASDAQ: L...
Více zde

LYELL IMMUNOPHARMA TO ACQUIRE IMMPACT BIO AND PRIORITIZES ITS PIPELINE TO FOCUS ON NEXT-GENERATION CAR T-CELL THERAPIES

24-10-2024
SOUTH SAN FRANCISCO, CALIF., OCT. 24, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES THE ACCEPTANCE ABSTRACTS FOR PRESENTATION AT 2024 SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING

04-10-2024
SOUTH SAN FRANCISCO, CALIF., OCT. 04, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES PARTICIPATION IN GOLDMAN SACHS CELL THERAPY DAY

24-09-2024
SOUTH SAN FRANCISCO, CALIF., SEPT. 24, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LY...
Více zde

LYELL IMMUNOPHARMA ANNOUNCES PARTICIPATION IN SEPTEMBER INVESTOR CONFERENCES

28-08-2024
SOUTH SAN FRANCISCO, CALIF., AUG. 28, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE SECOND QUARTER 2024

07-08-2024
SOUTH SAN FRANCISCO, CALIF., AUG. 07, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA REPORTS DOSE-DEPENDENT CLINICAL ACTIVITY FROM PHASE 1 TRIAL OF LYL797, A ROR1-TARGETED CAR-T CELL PRODUCT CANDIDATE ENHANCED WITH ITS PROPRIETARY ANTI-EXHAUSTION TECHNOLOGY

26-06-2024
SOUTH SAN FRANCISCO, CALIF., JUNE 26, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA TO PARTICIPATE IN THE GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE

03-06-2024
SOUTH SAN FRANCISCO, CALIF., JUNE 03, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

LYELL IMMUNOPHARMA TO PARTICIPATE IN BOFA SECURITIES HEALTH CARE CONFERENCE

07-05-2024
SOUTH SAN FRANCISCO, CALIF., MAY 07, 2024 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYEL...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-08 00:00:008-KStáhnout
2025-12-05 00:00:008-KStáhnout
2025-11-12 00:00:008-KStáhnout
2025-11-12 00:00:0010-QStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-03 00:00:008-KStáhnout
2025-09-16 01:00:008-KStáhnout
2025-09-16 00:00:008-KStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-07-25 01:00:008-KStáhnout
2025-07-25 00:00:008-KStáhnout
2025-06-26 01:00:008-KStáhnout
2025-06-26 00:00:008-KStáhnout
2025-06-17 01:00:008-KStáhnout
2025-06-17 00:00:008-KStáhnout
2025-06-09 01:00:008-KStáhnout
2025-06-09 00:00:008-KStáhnout
2025-05-28 01:00:008-KStáhnout
2025-05-28 00:00:008-KStáhnout
2025-05-21 01:00:008-KStáhnout
2025-05-21 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-04-01 01:00:008-KStáhnout
2025-04-01 00:00:008-KStáhnout
2025-03-11 00:00:008-KStáhnout
2025-03-11 00:00:0010-KStáhnout
2025-03-10 23:00:008-KStáhnout
2025-03-10 23:00:0010-KStáhnout
2025-01-24 00:00:008-KStáhnout
2025-01-23 23:00:008-KStáhnout
2024-12-10 00:00:008-KStáhnout
2024-12-09 23:00:008-KStáhnout
2024-11-26 00:00:008-KStáhnout
2024-11-25 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-31 00:00:008-KStáhnout
2024-10-30 23:00:008-KStáhnout
2024-10-24 01:00:008-KStáhnout
2024-10-24 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-06-26 01:00:008-KStáhnout
2024-06-26 00:00:008-KStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 01:00:0010-QStáhnout
2024-05-06 00:00:008-KStáhnout
2024-05-06 00:00:0010-QStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2023-11-20 00:00:008-KStáhnout
2023-11-19 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-09-11 01:00:008-KStáhnout
2023-09-11 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-21 01:00:008-KStáhnout
2023-06-21 00:00:008-KStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2022-12-16 00:00:008-KStáhnout
2022-12-15 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-10-24 01:00:008-KStáhnout
2022-10-24 00:00:008-KStáhnout
2022-10-06 01:00:008-KStáhnout
2022-10-06 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-03-29 01:00:008-KStáhnout
2022-03-29 01:00:0010-KStáhnout
2022-03-29 00:00:008-KStáhnout
2022-03-29 00:00:0010-KStáhnout
2022-02-15 00:00:008-KStáhnout
2022-02-14 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-12-03 00:00:008-KStáhnout
2021-12-02 23:00:008-KStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-12 00:00:0010-QStáhnout
2021-11-11 23:00:008-KStáhnout
2021-11-11 23:00:0010-QStáhnout
2021-10-28 01:00:008-KStáhnout
2021-10-28 00:00:008-KStáhnout
2021-09-30 01:00:008-KStáhnout
2021-09-30 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
preloader